At Parse Biosciences, we are propelling single cell science forward with constant innovation. We’re driven to deliver researchers new capabilities that push the limits of what’s possible.
Single cell sequencing is enabling breakthroughs in developmental biology, stem cell therapy, immunotherapy, our understanding of COVID-19, and treatments in neurology, diabetes, vascular injury and disease, and cancer. New areas of inquiry are constantly unfolding, and Parse will continue supporting the trailblazing researchers that are leading the way.
Built on a foundation of groundbreaking science, Parse Biosciences is setting a course of rapid innovation.